What are the causes, symptoms, diagnostic criteria, and management strategies for pre‑diabetes and type 2 diabetes for the Canadian NAC OSCE?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 17, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Pre-Diabetes and Type 2 Diabetes: NAC OSCE Canada Guide

PRE-DIABETES

What is Pre-Diabetes?

Pre-diabetes means your blood sugar is higher than normal but not yet high enough to be called diabetes 1. Think of it as a warning sign—your body is struggling with sugar control, but you can still turn things around.

Causes of Pre-Diabetes

  • Insulin resistance: Your body's cells don't respond well to insulin (the hormone that moves sugar from blood into cells)
  • Excess body weight: Fat, especially around your belly, makes insulin work less effectively 1
  • Physical inactivity: Not exercising worsens insulin resistance 1
  • Genetics: Family history of diabetes increases risk 1
  • Age: Risk increases after age 40 1
  • Previous gestational diabetes (diabetes during pregnancy) 1
  • Ethnicity: Higher risk in African Americans, Hispanic/Latino, Native Americans, Asian Americans, Native Hawaiians and Pacific Islanders 1

Important caveat: Asian Americans develop diabetes at lower body weights—about 15 pounds less than other populations 1.

Symptoms of Pre-Diabetes

Here's the tricky part: pre-diabetes usually has NO symptoms 2. This is why screening is so important. You feel completely fine while your body is already developing problems.

Diagnosis of Pre-Diabetes

Screen adults over 45 years old every 3 years, or earlier/more frequently if they have risk factors 3. Use the ADA risk test (score ≥5 indicates high risk) 1.

Diagnostic criteria (any ONE of these):

  • Fasting plasma glucose: 5.6–6.9 mmol/L (100–125 mg/dL)
  • 2-hour glucose on oral glucose tolerance test: 7.8–11.0 mmol/L (140–199 mg/dL)
  • A1C: 5.7–6.4% 4, 2

Once diagnosed, monitor for progression to diabetes at least annually 4.

Management of Pre-Diabetes

Lifestyle modification is the absolute cornerstone—this is non-negotiable and more effective than medication 2, 5, 6.

Lifestyle Changes (First-line for ALL patients):

  • Weight loss: Target 5-10% body weight reduction
  • Physical activity: 150 minutes/week of moderate exercise
  • Diet: Reduce refined carbohydrates, added sugars, sugar-sweetened beverages; emphasize whole, minimally processed foods 7
  • Avoid ultra-processed foods 7

Medications (for high-risk patients or when lifestyle fails):

  • Metformin: First choice for medication, especially if BMI ≥35, age <60, or history of gestational diabetes 5, 6
  • Acarbose: Alternative option 5
  • Thiazolidinediones: For very high-risk patients who progress despite intensive lifestyle changes 5

Vitamin D supplementation may reduce progression to diabetes in deficient individuals with high metabolic risk 8, though this is emerging evidence.


TYPE 2 DIABETES

What is Type 2 Diabetes?

Type 2 diabetes accounts for 90-95% of all diabetes 1. Your body has both insulin resistance (cells don't respond to insulin) AND relative insulin deficiency (pancreas doesn't make enough insulin) 1.

Causes of Type 2 Diabetes

  • Insulin resistance: Decreased biological response to insulin 1
  • Beta cell dysfunction: Pancreas can't produce enough insulin to overcome resistance 9
  • Excess body weight/obesity: Most (but not all) patients have overweight or obesity 1
  • Abdominal fat distribution: Even normal-weight people with belly fat are at risk 1
  • Genetics: Strong family history component 1
  • Physical inactivity 1
  • Age, ethnicity (same risk factors as pre-diabetes) 1

Symptoms of Type 2 Diabetes

Type 2 diabetes frequently goes undiagnosed for YEARS because hyperglycemia develops gradually 1. Early stages often have no symptoms.

Classic symptoms when present:

  • Polyuria (excessive urination)
  • Polydipsia (excessive thirst)
  • Dehydration
  • Unintentional weight loss
  • Blurred vision
  • Fatigue

Critical pitfall: Even without symptoms, patients are developing macrovascular (heart disease, stroke) and microvascular (kidney, eye, nerve) complications 1.

Diagnosis of Type 2 Diabetes

Screen adults over 45 every 3 years; screen earlier/more frequently with risk factors 3.

Diagnostic criteria (any ONE of these):

  • Fasting plasma glucose ≥7.0 mmol/L (126 mg/dL) 3
  • 2-hour glucose on oral glucose tolerance test ≥11.1 mmol/L (200 mg/dL)
  • A1C ≥6.5%
  • Random glucose ≥11.1 mmol/L with symptoms

Note: The fasting glucose threshold was lowered from 7.8 to 7.0 mmol/L to improve sensitivity and catch more cases early 3.

Management of Type 2 Diabetes

Management must address BOTH glucose control AND cardiovascular risk factors (hypertension, dyslipidemia) 10, 6.

Step 1: Lifestyle Modification (Foundation for ALL patients)

  • Weight loss: Target 5-10% reduction if overweight/obese 6
  • Physical activity: 150 minutes/week moderate exercise
  • Diet: Whole foods, minimize ultra-processed foods, refined carbs, added sugars, sugar-sweetened beverages 7
  • Limit saturated fat to <10% of energy 7

Protein intake: 1.2-1.6 g/kg/day recommended, but use caution in patients with or at risk for chronic kidney disease 7.

Step 2: Pharmacological Treatment

Use a complications- and comorbidities-centric approach, not just glucose levels 6.

First-line medication choices based on patient profile:

  • If cardiovascular disease or high CV risk: GLP-1 receptor agonist or SGLT2 inhibitor with proven CV benefit 6
  • If heart failure or chronic kidney disease: SGLT2 inhibitor 6
  • If obesity is prominent: GLP-1 receptor agonist (also helps weight loss) 6
  • If no specific comorbidities: Metformin is traditional first-line 6

Insulin therapy: Initiate when oral agents fail to achieve glycemic targets or in severe hyperglycemia 6.

Step 3: Glycemic Targets

Strive for tight metabolic control to achieve optimal glucose levels 3. This requires:

  • Diabetes education through healthcare team
  • Diligent self-monitoring of blood glucose
  • Stepwise adjustments in medications 3

Duration of glycemic burden is a strong predictor of adverse outcomes—early aggressive control matters 1.

Step 4: Cardiovascular Risk Management

  • Hypertension control: Treat to target 6
  • Dyslipidemia management: Statin therapy for most patients 6
  • Antiplatelet therapy: Consider in appropriate patients 6

Step 5: Surveillance for Complications

Simple tests to detect preclinical disease are readily available 1. Screen regularly for:

  • Retinopathy: Annual eye exams
  • Nephropathy: Annual urine albumin and kidney function
  • Neuropathy: Annual foot exams
  • Cardiovascular disease: Risk assessment

Vaccinations

Adults with diabetes need specific vaccines 6—ensure up-to-date immunizations.


Key Differences: Pre-Diabetes vs Diabetes

Feature Pre-Diabetes Type 2 Diabetes
Symptoms Usually NONE [2] Often none early; classic symptoms later [1]
Reversibility Can revert to normal with lifestyle changes [2,11] Chronic condition requiring ongoing management
Treatment priority Lifestyle modification first [2,5] Lifestyle + medications based on comorbidities [6]
Monitoring At least annually [4] Ongoing with A1C every 3-6 months
Complications Increased CV risk [2] Macro- and microvascular complications [1]

NAC OSCE Pearls

For pre-diabetes:

  • Emphasize that it's reversible with lifestyle changes 2, 11
  • Screen high-risk patients even if asymptomatic
  • Lifestyle modification is MORE effective than metformin long-term 2

For type 2 diabetes:

  • Often diagnosed late because symptoms develop gradually 1
  • Complications may already be present at diagnosis 1
  • Treatment must be individualized based on comorbidities, not just glucose 6
  • Asian patients develop diabetes at lower BMI 1

References

Research

Risk and management of pre-diabetes.

European journal of preventive cardiology, 2019

Research

1998 clinical practice guidelines for the management of diabetes in Canada. Canadian Diabetes Association.

CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne, 1998

Research

What is the best treatment for prediabetes?

Current diabetes reports, 2009

Research

American Association of Clinical Endocrinology Consensus Statement: Algorithm for Management of Adults With Type 2 Diabetes - 2026 Update.

Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists, 2026

Related Questions

In a 52‑year‑old patient with a newly discovered firm, non‑tender lump on the left posterior thoracic region and a history of prediabetes, what is the recommended clinical evaluation and imaging work‑up?
The patient has had prediabetes for 5 months with otherwise normal labs; should the glucose assessment be repeated now?
What biomarkers identify subclinical inflammation in diabetes or prediabetes?
For a patient now in the prediabetes range, is yearly retinal screening and podiatry review necessary?
How can I determine if I remain prediabetic given my fatigue, insomnia, and hyperinsulinemia?
What is the appropriate assessment and management for a child presenting with chest pain at rest?
Given a normal prostate‑specific antigen, normal comprehensive metabolic panel except a mildly elevated serum creatinine of 1.1 mg/dL and low‑normal alanine aminotransferase of 14 U/L, with normal lipid profile and complete blood count, what is the appropriate management?
Should I perform a bronchodilator test or a methacholine challenge test to evaluate suspected asthma?
What is the indication for losartan 100 mg combined with hydrochlorothiazide 12.5 mg?
How should I manage a 50‑year‑old woman with CT‑proven mucus plugging in multiple lung segments, who is on hydroxyzine, cetirizine, duloxetine, gabapentin, low‑dose oral methylprednisolone, inhaled budesonide/formoterol, albuterol, fluticasone nasal spray, montelukast, and other medications, given the differential of bronchiolitis versus reactive airway disease?
What is the recommended intravenous infusion dose of levosimendan, including loading bolus and infusion rate adjustments?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.